Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Journal of NeuroVirology
Erschienen in:

19.11.2024 | Case Report

A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature

verfasst von: Erfan Shahabinejad, Amirreza Shakoeizadeh, Alireza Vakilian, Seyyed Mohammad Alipour, Fatemeh Jalali, Faezeh Ebrahimi, Narges Mashyekhi

Erschienen in: Journal of NeuroVirology | Ausgabe 5-6/2024

Einloggen, um Zugang zu erhalten

Abstract

Guillain-Barre Syndrome (GBS) is a rare but serious neurological disorder characterized by acute flaccid paralysis and areflexia, usually after an infectious disease. This case report describes a previously healthy 9-year-old boy who developed GBS following an acute hepatitis A infection. The patient presented with rapidly progressive weakness, ascending paralysis, and areflexia, confirmed by clinical and electrophysiological findings. Results were consistent with the GBS subgroup of Acute Motor Axonal Neuropathy. Treatment with intravenous immunoglobulin (IVIG) led to gradual improvement, highlighting the importance of early recognition and intervention. This report reviews the current literature on the association between GBS and hepatitis A, emphasizing the rarity of such cases in pediatric populations. The report aims to raise awareness among clinicians about this potential complication of hepatitis A, underscoring the need for prompt diagnosis and treatment to improve outcomes in similar cases. The report emphasizes the need for prompt diagnosis and treatment to improve outcomes in similar cases.
Literatur
Abubakar A, Murdia M, Diana D (2023) Neurological uniqueness: a case study of Hepatitis A-Induced Acute Inflammatory demyelinating polyneuropathy. Indonesian J Case Rep 1(1):19–23CrossRef
Ahmed A, EL‐Sadig SM, Siddig EE (2023) Guillain–Barre syndrome associated with hepatitis E virus infection: a case report. Clin Case Rep 11(9)
Azuri J, Lerman-Sagie T, Mizrahi A, Bujanover Y (1999) Guillain-Barre syndrome following serological evidence of hepatitis A in a child. Eur J Pediatr 158(4):341–342CrossRefPubMed
Bae YJ, Kim KM, Kim KK, Rho JH, Lee HK, Lee YS et al (2007) A case of acute hepatitis a complicated by Guillain-Barre syndrome. Korean J Hepatol 13(2):228–233PubMed
Baltadzhiev I, Geneva I, Popivanova N (2018) Guillain-Barré syndrome in a child with ongoing viral Hepatitis A. Iran J Child Neurol 12(3):133–138PubMedPubMedCentral
Boccia F, Florio LL, Durante-Mangoni E, Zampino R (2023) Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C. J Neurovirol 29(5):640–643CrossRefPubMedPubMedCentral
Bosch VV, Dowling PC, Cook SD (1983) Hepatitis A virus immunoglobulin M antibody in acute neurological disease. Annals Neurology: Official J Am Neurol Association Child Neurol Soc 14(6):685–687CrossRef
Budumuru U, Muralidharan K, Sowmini P, Velayutham SS, Jeyaraj KM, Saravanan RV et al (2023) AMAN with ophthalmoparesis: a rare presentation. J Assoc Phys India 71(11):103–104
Busl KM, Fried H, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA et al (2023) Guidelines for neuroprognostication in adults with guillain–barré syndrome. Neurocrit Care 38(3):564–583CrossRefPubMedPubMedCentral
Chimegave AA, Vagha KJ (2023) Guillain-Barré syndrome in children: a narrative review. J Datta Meghe Inst Med Sci Univ 18(3):549–552CrossRef
Chitambar SD, Fadnis RS, Joshi MS, Habbu A, Bhatia S (2006) Case report: hepatitis a preceding Guillain–Barré syndrome. J Med Virol 78(8):1011–1014CrossRefPubMed
Chua P, (n.d)GUILLAIN BARRE SYNDROME FOLLOWING ACUTE HEPATITIS A INFECTION: A CASE REPORT
Dunk A, Jenkins W, Sherlock S (1982) Guillain-Barré syndrome associated with hepatitis A in a male homosexual. Sex Transm Infect 58(4):269–270CrossRef
Finsterer J (2002) Triggers of guillain–barré syndrome: campylobacter jejuni predominates. Int J Mol Sci 23(22):14222CrossRef
Gawande I, Akhuj A, Samal S (2024) Effectiveness of physiotherapy intervention in guillain barre syndrome: a case report. Cureus 16(1)
Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D (1992) Relapsing hepatitis A review of 14 cases and literature survey. Medicine 71(1):14–23CrossRefPubMed
Igarashi M, Tomono M, Uchida S, Yamashiro Y, Namihisa T, Tanaka S (1983) Guillain-Barré syndrome associated with acute hepatitis A. Gastroenterol Japonica 18:549–552CrossRef
Jo Y-S, Han S-D, Choi J-Y, Kim IH, Kim Y-D, Na S-J (2013) A case of acute motor and sensory axonal neuropathy following hepatitis a infection. J Korean Med Sci 28(12):1839–1841CrossRefPubMedPubMedCentral
Jung ES, Kim YS, Min J-H, Kang K, Lee JJ, Park J-M et al (2017) Acute-onset chronic inflammatory demyelinating polyneuropathy following hepatitis A virus infection. Annals Clin Neurophysiol 19(1):50–53CrossRef
Kadanali A, Kizilkaya M, Tan H, Erol S, Tasyaran MA, Parlak M (2006) An unusual presentation of hepatitis a virus infection: Guillain-Barré syndrome. Trop Doct 36(4):248CrossRefPubMed
Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (2015) Harrison’s principles of internal medicine (2 vols). McGraw-Hill Education
Kocabas E, Yildizdas D (2004) A child with Guillain-Barre syndrome caused by acute hepatitis a infection. Indian Pediatr 41(1):92–93PubMed
Kocabas E (2004) A child with Guillain-Barre syndrome caused by acute hepatitis a infection. Indian Pediatr 41(1):92–93PubMed
Aswanth KS, Kumar V, Raj A, Bhat NK (2023) Acute liver failure due to hepatitis a virus presented with Guillain-Barré syndrome and ocular myasthenia gravis. BMJ Case Rep 16(10):e254855
Lee D-K, Do J-K, Kim Y-J (1997) Guillain-Barre like syndrome associated with acute renal failure and thrombocytopenia following acute viral hepatitis A. J Korean Med Sci 12(2):151–156CrossRefPubMedPubMedCentral
Lv J, Zhaori G (2022) Collaborative studies of US-China neurologists on acute motor axonal neuropathy. Pediatr Invest 6(01):1–4CrossRef
Mardani M, Khodashahi R, Faghani Y (2020) Guillain-Barre Syndrome Associated with Acute Hepatitis a infection: a Case Report. Asian J Case Rep Med Health 3(1):21–25
Nemakayala D, Reif M, Welch A, Young S (2021) S2598 Acute hepatitis a complicated by Guillain-Barré syndrome. Official journal of the american college of gastroenterology ACG 116:S1093
Nicolás-Sánchez FJ, Pujol-Sabaté M, Nicolás-Sarrat FJ, Sarrat-Nuevo RM (2022) Acute motor axonal neuropathy associated with the Pfizer SARS-CoV-2 vaccine. Neurol Perspect 2(4):259–262CrossRefPubMedPubMedCentral
Nomani AZ, Uzma Jamil UJ, Zakir Jan ZJ, Rajput HM, Mansoor Iqbal MI, Tanich HB, Khan RS, Muhammad Irshad MI, Mazhar Badshah MB (2015) Novel association of GBS: post-hepatitis demyelinating motor neuropathy
Ono S-i, Chida K, Takasu T (1994) Guillain-Barré syndrome following fulminant viral hepatitis A. Intern Med 33(12):799–801CrossRefPubMed
Patel S, Anand I, Batra A, Gupta P, Agrawal R (2015) Guillain-Barre Syndrome Associated with Acute Hepatitis a infection. Am J Clin Neurol Neurosurg 1(1):10–12
Pelletier G, Elghozi D, Trépo C, Laverdant C, Benhamou J-P (1985) Mononeuritis in acute viral hepatitis. Digestion 32(1):53–56CrossRefPubMed
Rodrigues RA, Sequeira M, Barros F, Alves T, Gonçalves J (2023) Acute hepatitis e-associated Guillain-Barré syndrome. Cureus 15(11)
Samadi A, Mansour-Ghanaei F, Joukar F, Mavaddati S, Sufi Afshar I (2019) A 30-Year-old man with Acute Motor Axonal Neuropathy Subtype of Guillain-Barré Syndrome having Hepatitis a virus infection. Middle East J Dig Dis 11(2):110–115CrossRefPubMedPubMedCentral
Sharma B, Nagpal K, Handa R, Dubey P (2013) Combination of AIDP and pyramidal signs associated with antecedent hepatitis a infection: a rare (co) occurrence. Case Rep 2013:bcr2013009530
Shrestha GS, Rimal A (2024) Guillain-Barré Syndrome and Neurocritical Care. Principles and practice of Neurocritical Care. Springer, pp 729–742CrossRef
Shubhakaran KP (2019) Guillain Barre Syndrome in Hepatitis A; a Case Report with Review of Literature. EC Microbiol 15:368–371
Thapa R, Biswas B, Mallick D, Mukherjee S (2009) Pharyngeal-cervical-brachial variant of pediatric Guillain-Barré syndrome with antecedent acute hepatitis a virus infection. J Child Neurol 24(7):865–867CrossRefPubMed
Traub R, Chaudhry V (eds) (2023) Neuroprognostication: Guillain–Barré Syndrome. Seminars in neurology. Thieme Medical Publishers, Inc.
van Doorn PA, Van den Bergh PY, Hadden RD, Avau B, Vankrunkelsven P, Attarian S et al (2023) European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome. J Peripheral Nerv Syst 28(4):535–563CrossRef
Wankhade S, Qureshi MI, Kovela RK, Menon S, Bele AW (2024) Effectiveness of focused and goal-oriented physiotherapy in the recovery of a patient with Guillain–Barré syndrome
Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain-Barre syndrome. Lancet 388(10045):717–727CrossRefPubMed
최형우, 김영돈 (2022) 천갑진. A case of Guillain-Barré syndrome following acute viral hepatitis A. 대한내과학회 추계학술발표논문집 2022(2):56PubMed
Metadaten
Titel
A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature
verfasst von
Erfan Shahabinejad
Amirreza Shakoeizadeh
Alireza Vakilian
Seyyed Mohammad Alipour
Fatemeh Jalali
Faezeh Ebrahimi
Narges Mashyekhi
Publikationsdatum
19.11.2024
Verlag
Springer International Publishing
Erschienen in
Journal of NeuroVirology / Ausgabe 5-6/2024
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-024-01237-4

Weitere Artikel der Ausgabe 5-6/2024

Regulation of voltage-gated sodium channels by TNF-α during herpes simplex virus latency establishment

Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants

Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications

  • Open Access
  • Review

Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases

  • Research

Greater humoral EBV response may be associated with choroid plexus inflammation in progressive MS

  • Brief Report

Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Podcast

Vom Wert der Ernährung bei neurodegenerativen Erkrankungen

Am Beispiel Parkinson zeigt sich, dass Ernährung nicht nur präventiv förderlich ist, sondern auch die Wirkung von Medikamenten und den Krankheitsverlauf beeinflusst. Prof. Dr. Andrés Ceballos-Baumann, München, fasst die aktuelle Studienlage zusammen, nennt die bestehenden Probleme und veranschaulicht seine Vorgehensweise.

Passen Psychopharmaka und Pille zusammen?

Wie relevant Wechselwirkungen zwischen hormonellen Kontrazeptiva und Psychopharmaka sein können, schilderte Dr. med. Dominik Dabbert beim diesjährigen FOKO. Worauf es in der Praxis ankommt und wie gefährliche Wechselwirkungen vermieden werden können, lesen Sie hier. 

ePA: Entlastung oder Mehrarbeit?

Die elektronische Patientenakte (ePA) soll das Gesundheitswesen revolutionieren. Mit über 2000 Krankenhäusern und mehr als 100.000 ärztlichen Praxen ist sie eines der größten Digitalisierungsprojekte Europas. Während die Politik die ePA als „Gamechanger“ feiert, zeigt sich in der Praxis ein anderes Bild.

Einjährige Valaciclovir-Therapie schützt nicht vor Zoster-Rezidiv

Die Zoster Eye Disease Study (ZEDS) liefert gleich zwei ernüchternde Erkenntnisse: Eine einjährige Therapie mit niedrig dosiertem Valaciclovir kann weder einen Herpes zoster ophthalmicus (HZO) noch eine Post-Zoster-Neuralgie (PZN) verhindern.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise